Albert David Ltd is engaged in manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export.
Financial Results:
Albert David Ltd reported Revenues for Q1FY24 of ₹92.00 Crores down from ₹93.00 Crore year on year, a fall of 1.08%.
Total Expenses for Q1FY24 of ₹81.00 Crores down from ₹83.00 Crores year on year, a fall of 2.41%.
Consolidated Net Profit of ₹23.00 Crores up 1050.0% from ₹2.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹41.16, up 1,236.36% from ₹3.08 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.